People with multiple NAION risk factors such as sleep apnoea, high blood pressure and diabetes should undergo careful consideration with their treating doctor before starting these medications
(Rinse twice more than usual to ensure no residues are left behind
At the same time, it is important to keep our feet on the ground.Some programs have stalled on efficacy or safety, such as Terns disappointing phase II readout or Pfizers discontinuation of danuglipron due to concerns around liver toxicity
Drugs 71:611624 Seino Y, Fukushima M, Yabe D (2010) GIP and GLP-1, the two incretin hormones: Similarities and differences
This binding triggers multiple physiological responses that contribute to glycemic control and weight reduction
These drugs slow digestion, which makes these problems worse